Monocytic microRNAs-Novel targets in atherosclerosis therapy

Area of Science:

• Vascular Biology
• Immunology
• Molecular Medicine

Background:

• Atherosclerosis is a chronic inflammatory vascular disease driven by monocytes/macrophages.
• Macrophage polarization imbalance and cholesterol accumulation contribute to plaque instability.
• MicroRNAs (miRs) are emerging regulators of monocyte/macrophage function in atherosclerosis.

Purpose of the Study:

• To review the role of monocyte/macrophage-derived miRs in atherosclerosis.
• To explore the therapeutic potential of miRs in modulating macrophage behavior.
• To identify novel treatment strategies for atherosclerosis using miR-based interventions.

Main Methods:

• Literature review focusing on microRNA involvement in monocyte/macrophage biology.
• Analysis of studies investigating miR effects on macrophage polarization and foam cell formation.
• Examination of research on miR mimics and antagomiRs for therapeutic applications.

Main Results:

• Dysregulated macrophage polarization, influenced by miRs, promotes atherosclerosis.
• MiRs modulate key pro-atherosclerotic processes like cholesterol uptake and efferocytosis.
• Targeting specific miRs can potentially reverse or halt atherosclerotic progression.

Conclusions:

• Monocyte/macrophage-derived miRs are critical players in atherosclerosis pathogenesis.
• miR-based therapies (mimics/antagomiRs) represent a promising avenue for treating atherosclerosis.
• Further research into miR regulation of macrophage function could yield significant clinical benefits.